Navigation Links
WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
Date:7/29/2010

p>

"All of our businesses are performing very well," Dr. Li continued. "Each business unit has met or exceeded its targets for the second quarter, and we recently increased our guidance for full-year 2010 financial performance.

"Virtually all of the large global pharmaceutical companies, as well as hundreds of smaller pharmaceutical and biotech companies and many leading medical device companies, are our customers," Dr. Li concluded. "We believe that strong trends for greater outsourcing and offshoring of R&D services will continue, and that WuXi, as the leading China-based contract research organization, is well positioned to benefit from this powerful outsourcing trend for many years to come."

Second Quarter Results

WuXi will report financial results for the second quarter ending June 30, 2010, on Monday, August 2, at 6:30 am EDT with a conference call at 8:30 am EDT to discuss the results and the outlook for WuXi's business. The conference call may be accessed by calling:

    United States: 1-866-519-4004
    China (Landline): 800-819-0121
    China (Mobile): 400-620-8038
    Hong Kong: 800-930-346
    United Kingdom: 0-808-234-6646
    International: +65-6723-9381
    Conference ID: 90840146
    Web PIN: 8656

    A replay will be available two hours after the call's completion at:

    United States: 1-866-214-5335
    China North: 10-800-714-0386
    China South: 10-800-140-0386
    Hong Kong: 800-901-596
    United Kingdom: 0-800-731-7846
    International: +61-2-8235-5000
    Passcode: 90840146

A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
2. WuXi PharmaTech Announces First-Quarter 2010 Results
3. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
4. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
5. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
6. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
7. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
8. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
9. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
10. Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
11. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 Arbor Pharmaceuticals, ... Summary Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. ... overview of the Arbor Pharmaceuticals, LLC.,s pharmaceutical research ... information on the current therapeutic developmental pipeline of ... various stages, therapeutics assessment by drug target, mechanism ...
(Date:9/30/2014)... DENVER , Sept. 30, 2014  According ... "the world of cancer clinical trials is going ... clinical trials and the work of the current ... these types of ,next generation, clinical trials, which ... tomorrow."  The company has been ...
(Date:9/30/2014)... , Sept. 30, 2014 A study ... (OCT), offered a new look at the composition of ... how physicians understand and treat the disease, a leading ... at Baptist Health Lexington between September 2010 and May ... the Journal of the American College of Cardiology ...
Breaking Medicine Technology:Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... cytokine called IL-35 could allow clinicians to,treat diseases by ... Tenn., Nov. 21 Investigators at St.,Jude Children,s Research ... responses from running amok and damaging the body. The,finding ... cancer, using,vaccines; for autoimmune diseases, such as Type 1 ...
... A new study,released by Indiana University researchers shows ... significant improvements in heart,health, particularly in nonsmokers. The ... for heart attacks, also known as acute myocardial,infarctions ... in Monroe,County, Indiana versus the control county during ...
Cached Medicine Technology:St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases 2Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows 2
(Date:10/1/2014)... Physical Sciences Research Council (EPSRC) will focus on ... systems which run, for example, manufacturing plants, power ... , The research will help understand and ... systems behind our critical national infrastructure. , ... (RITICS), based at Imperial College London, is co-ordinating ...
(Date:10/1/2014)... 2014 Familylifeinsurancequotes.org has released a ... for senior citizens. , Senior citizens can qualify ... sell coverage to seniors who are over 50 years ... without taking a medical examination. , Term life insurance ... senior clients can qualify. Having life insurance during retirement ...
(Date:10/1/2014)... 2014 Lifeinsurance-policy.com has released a ... life insurance prices for smokers. , Smoking will always ... Comparing quotes is the best method to find affordable ... customers who need coverage. , Whole life insurance ... the policy. Since the coverage is permanent, the initial ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
(Date:10/1/2014)... October 01, 2014 Between 23 million ... the U.S., according to figures from the National Institutes ... Association (AARDA), and many of them have something else ... having undiagnosed celiac disease. Gluten Free Therapeutics, makers ... of undiagnosed celiac disease by publishing a series of ...
Breaking Medicine News(10 mins):Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... 35% More Weight and Have Better Quality of,Life, ... GAINESVILLE, Fla., Oct. 28 Those patients who ... 35,percent more weight the first year and tend to ... new patient and bariatric surgeon surveys,conducted by Harris Interactive(R), ...
... protect all, studies show shots cut deaths, hospital visits ... people who get the flu vaccine, the better it ... In the first study, researchers from the Institute for ... a universal vaccination program implemented in the Ontario province ...
... Also Underscores High Level of Patient Dissatisfaction with ... am PDT -- UCB announced,today findings from large-scale ... that showed patients rating themselves,as having substantially less ... believed. The survey also showed disagreement between,physicians and ...
... Cardiogenesis,Corporation (Pink Sheets: CGCP), announced that the company ... 30, 2008 prior to market open,on Thursday, November ... P. Lanigan and Senior Vice President and Chief ... conference call that day at 12:00,p.m. Eastern time ...
... Oct. 28 Pharmasset, Inc.,(Nasdaq: VRUS ) today ... American Association for the Study of Liver Diseases (AASLD) ... During this webcast, management,will review Pharmasset,s progress on the ... To access a simultaneous webcast of this event ...
... IOP of 20% from baseline at 12 weeks ... QLTI;,TSX: QLT) ("QLT" or the "Company") today announced data ... by QLT,s wholly-owned subsidiary,QLT Plug Delivery, Inc. (QPD), to ... Delivery System (L-PPDS) for the treatment of open,angle glaucoma ...
Cached Medicine News:Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 2Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 3Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 4Health News:New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery 5Health News:When It Comes to Flu, the More Who Get Vaccine, the Better 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 2Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 3Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 4Health News:New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers 5Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 2Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 3Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 2Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 3Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 4Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 5Health News:QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System 6
... Trocar is a full-featured trocar that consists of ... shield. The shield is designed to cover the ... puncture or laceration once the abdominal or thoracic ... option is designed to enhance trocar sleeve fixation ...
... trocar that consists of a sharp pyramidal blade, ... cover the pyramidal tip to protect internal structures ... thoracic cavity has been entered. Due to reduced ... not required. , ,The single-patient use trocar ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: